Current Studies
Complex Regional Pain Syndrome Study
This study is currently enrolling eligible adults in the CRPS-RISE Phase 3 Clinical Trial.
Fibromyalgia Study
Coming soon: a study for adults 18 and older with fibromyalgia who have tried two or more therapies that didn’t work.
Type 2 Diabetes Study
Coming soon: a study for adults 18 and older with type 2 diabetes who are not taking insulin, a GLP-1, or a DPP-4 medication.
Knee Pain Study
We’re preparing an upcoming knee pain study. Join our notification list and we’ll contact you as soon as enrollment opens.
Back Pain Study
We’re preparing an upcoming back pain study. Join our notification list and we’ll contact you as soon as enrollment opens.
This study is now closed, but we expect new trials in the future. If you or a loved one has mild cognitive impairment or mild Alzheimer’s dementia, contact us and we’ll reach out when a new study opens.
Neurovations
Neurovations, a patient care and innovation company, was founded in 1992 by CEO Dr. Eric Grigsby. Today, Neurovations is a national leader in medical device and pharmaceutical innovation, clinical research, and a world-class education program focusing in pain and neuroscience. Dr. Grigsby is deeply connected to the healthcare community through our non-profit HealthRoots Foundation.
Our unwavering mission is to inspire hope and to contribute to the health and well-being of our patients and communities through integrated clinical practice, research, and education.